Evidence map›Paper›PMID 23918763›Full record

ArticleAmerican journal of medical genetics. Part A2013

Expanding the SHOC2 mutation associated phenotype of Noonan syndrome with loose anagen hair: structural brain anomalies and myelofibrosis.

Karen W Gripp, Dina J Zand, Laurie Demmer, Carol E Anderson, William B Dobyns, Elaine H Zackai, Elizabeth Denenberg, Kim Jenny, Deborah L Stabley, Katia Sol-Church

Open access · greenAbstract readCase Reports
In one paragraph

Article in American journal of medical genetics. Part A, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Restoring the 14-3-3/CRAF regulatory interaction in Noonan syndrome using molecular glues.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. The Genetics of Chiari 1 Malformation.Journal of clinical medicine · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Cancer incidence and surveillance strategies in individuals with RASopathies.American journal of medical genetics. Part C, Seminars in medical genetics · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Case report: AFrontiers in genetics · 2022
    Article
  19. Clinical report of a brain magnetic resonance imaging finding in Noonan syndrome.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Karen W GrippDivision of Medical Genetics, A. I. duPont Hospital for Children, Wilmington, Delaware.
Dina J Zand
Laurie Demmer
Carol E Anderson
William B Dobyns
Elaine H Zackai
Elizabeth Denenberg
Kim Jenny
Deborah L Stabley
Katia Sol-Church
Community Health Systems - Dupont Hospital · USNemours Children’s Clinic · USChildren's Hospital of Philadelphia · USChildren's National · USLevine Children's Hospital · USSt. Christopher's Hospital for Children · US

Funding

Center for Pediatric ResearchP20GM103464 · NIGMS · NEMOURS CHILDREN'S HOSPITAL, DELAWARE · PI SHAFFER, THOMAS H · 2012 to 2014
$5.6M
NIGMS NIH HHS 8P20GM103464-08NIGMS NIH HHS P20 GM103464
6 · The paper itself

Abstract

Noonan syndrome is a heterogenous rasopathy typically presenting with short stature, characteristic facial features, cardiac abnormalities including pulmonic valve stenosis, ASD and hypertrophic cardiomyopathy (HCM), cryptorchidism, ectodermal abnormalities, and learning differences. The phenotype is variable, and limited genotype phenotype correlation exists with SOS1 mutations often associated with normal cognition and stature, RAF1 mutations entailing a high HCM risk, and certain PTPN11 mutations predisposing to juvenile myelomonocytic leukemia. The recently identified SHOC2 mutation (p.Ser2Gly) causes Noonan syndrome with loose anagen hair. We report five patients with this mutation. All had skin hyperpigmentation, sparse light colored hair, increased fine wrinkles, ligamentous laxity, developmental delay, and 4/4 had a structural cardiac anomaly. Hypotonia and macrocephaly occurred in 4/5 (80%); 3/5 (60%) had polyhydramnios, increased birth weight or required use of a feeding tube. Distinctive brain abnormalities included relative megalencephaly and enlarged subarachnoid spaces suggestive of benign external hydrocephalus, and a relatively small posterior fossa as indicated by a vertical tentorium. The combination of a large brain with a small posterior fossa likely resulted in the high rate of cerebellar tonsillar ectopia (3/4; 75%). Periventricular nodular heterotopia was seen in one patient with a thick and dysplastic corpus callosum. We report on the first hematologic neoplasm, myelofibrosis, in a 2-year-old patient with SHOC2 mutation. Myelofibrosis is exceedingly rare in children and young adults. The absence of a somatic JAK2 mutation, seen in the majority of patients with myelofibrosis, is noteworthy as it suggests that germline or somatic SHOC2 mutations are causally involved in myelofibrosis.

Indexed as

MutationPhenotypeAbnormalities, MultipleAdultBrainChild, PreschoolFatal OutcomeFemaleHairHumansIntracellular Signaling Peptides and ProteinsMagnetic Resonance ImagingMaleNoonan SyndromePrimary MyelofibrosisYoung AdultIntracellular Signaling Peptides and ProteinsSHOC2 protein, humanChiari 1 malformationheterotopiamalignancymyelofibrosisNoonan syndrome with loose anagen hairrasopathySHOC2

Identifiers

PMID23918763
PMCPMC3787995
OpenAlexW1979945629

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.